The polymer Carragelose®, a unique broadly active anti-viral compound for treating respiratory diseases that has been approved for marketing in the EU, parts of Asia and Australia as part of an anti-viral nasal spray, throat spray and lozenges. It is a sulfated polymer from red seaweed also widely used in the food industry and has GRAS status (FDA). The compound has a broad spectrum of anti-viral properties and is supported with a strong patent family.
A cold comes three days - stays three days - leaves three days.
Colds are caused by more than 200 different respiratory viruses.
Like a burdock to textiles cold viruses bind to the surfaces of the upper respiratory tract.
Then the infection starts. It is time to interfere!
Sprayed into the nose Carragelose® creates a protective layer - incoming viruses can not infect cells - viruses already there cannot spread anymore!
The clotted viruses leave the body via the natural route - the cold might not even come, stay shorter or leave faster.
No Virus – No Cold – Naturally achieved
The safety and anti-viral effectiveness of Carragelose® have been established in several clinical and non-clinical trials. Three double-blind, placebo-controlled clinical trials confirmed the anti-viral effectiveness, a significant reduction of the duration of the disease, a significant reduction of viral load and a significant reduction of relapses.